Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
85.050
+1.260
+1.50%
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Sanofi SA (SASY)
Xetra
| Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| SASY | Paris | EUR | Real-time | |
| SASY | Derived | EUR | Real-time | |
| SANp | BATS Europe | EUR | Delayed | |
| SNY | NASDAQ | USD | Real-time | |
| 0O59 | London | EUR | Real-time | |
| SNYN | Mexico | MXN | Delayed | |
| SANF | Milan | EUR | Real-time | |
| SASY | Frankfurt | EUR | Delayed | |
| SASY | Xetra | EUR | Delayed | |
| SASY | TradeGate | EUR | Delayed |
Add to/Remove from a Portfolio
Add to Portfolio
- Volume: 6,713
- Bid/Ask: 84.630 / 85.500
- Day's Range: 84.090 - 85.440
Sanofi
85.050
+1.260
+1.50%
- General
- Chart
- News & Analysis
- Financials
- Technical
- Forum
- News
- Analysis & Comment
British stocks drop as prospect of no-deal Brexit grows
By Reuters - Dec 11, 2020
4
By Sagarika Jaisinghani and Shashank Nayar (Reuters) -London-listed shares ended lower on Friday as investors prepared for Britain to leave the European Union in three weeks without a trade deal,...
Five key genes linked to severe COVID-19 found, suggesting drug targets
By Reuters - Dec 11, 2020
By Kate Kelland LONDON (Reuters) - Five key genes are linked with the most severe form of COVID-19, scientists said on Friday, in research that also pointed to several existing drugs that could be...
AstraZeneca hitches ride with Russia's Sputnik in vaccine race
By Reuters - Dec 11, 2020
By Andrew Osborn and Pushkala Aripaka (Reuters) - AstraZeneca is to start clinical trials to test a combination of its experimental COVID-19 vaccine with Russia's Sputnik V shot to see if this can...
AirBnB Frenzy, FDA to Approve Pfizer Drug, No-Deal Brexit - What's up in Markets
By Investing.com - Dec 11, 2020
By Geoffrey Smith Investing.com -- AirBnB stokes the biggest IPO frenzy in 20 years, the FDA prepares to approve Pfizer’s Covid-19 drug and the EU and U.K. are heading for a messy divorce. Plus,...
UPDATE 1-UK Stocks-Factors to watch on Dec. 11
By Reuters - Dec 11, 2020
1
Dec 11 (Reuters) - Britain's FTSE 100 (.FTSE) index is seen opening 16 points lower at 6,584 on Friday, according to financial bookmakers, with futures (.FFIc1) down 0.1% ahead of the cash market...
Sanofi to publish COVID-19 vaccine price in development with GSK after Phase I/II trial results
By Reuters - Dec 03, 2020
PARIS (Reuters) - French drug maker Sanofi (PA:SASY) will announce the price of the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline after it has released Phase I/II results...
CureVac deal takes EU's COVID vaccine supplies close to two billion
By Reuters - Nov 16, 2020
By Francesco Guarascio BRUSSELS (Reuters) - The European Union has struck a deal for up 405 million doses of German biotech firm CureVac's (DE:5CV) potential COVID-19 vaccine, the head of the EU...
Exclusive: Europe to pay less than U.S. for Pfizer vaccine under initial deal - source
By Reuters - Nov 11, 2020
By Francesco Guarascio BRUSSELS (Reuters) - The European Union has struck a deal to initially pay less for Pfizer 's (N:PFE) COVID-19 vaccine candidate than the United States, an EU official told...
Exclusive: Europe to pay less than U.S. for Pfizer vaccine under initial deal - source
By Reuters - Nov 11, 2020
By Francesco Guarascio BRUSSELS (Reuters) - The European Union has struck a deal to initially pay less for Pfizer 's (N:PFE) COVID-19 vaccine candidate than the United States, an EU official told...
Activists urge 'Big Pharma' to be transparent on COVID-19 vaccine costs
By Reuters - Oct 29, 2020
1
By Stephanie Nebehay GENEVA (Reuters) - Activists called on pharmaceutical companies on Thursday to be transparent about the costs and terms of providing COVID-19 vaccines, saying they must be...
Write your thoughts about Sanofi SA
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Greg Greg
Dec 11, 2020 9:36
there is no future for it
0
5
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.